The convergence of diagnostic imaging, molecular biochemistry, and computational biology is altering the European digital health landscape. Zurich based preventive healthcare provider Aeon closed a strategic seed extension, expanding its cumulative seed financing past USD $14 million (surpassing €12 million) while simultaneously acquiring the core operational and technological assets of Berlin based blood diagnostics company Aware Health.